Scientists at deCODE genetics and collaborators have published a study in the Journal of Allergy and Clinical Immunology ...

"Tivic hits enrolment target for vagus nerve stimulation trial" was originally created and published by Medical Device ...

Analyst Ami Fadia of Needham maintained a Buy rating on Blueprint Medicines (BPMC – Research Report), retaining the price target of ...

The FDA has provided a date of April 18, 2025, to review the application for Dupixent to treat patients with chronic ...

GOP Senator Rand Paul's report on wasteful spending prompted a repost from Musk, who is spinning up an anti-wase project for ...

His nomination to head the HHS by President-elect Donald Trump on Thursday could bring sweeping changes to the way Washington, D.C., targets health issues.

Robert F. Kennedy Jr., now President-elect Donald J. Trump’s pick to lead the Department of Health and Human Services, has ...

Scientists at deCODE genetics, a subsidiary of Amgen, and collaborators have published a study in Journal of Allergy and ...

Martha Stewart, the queen of home and garden and America’s original influencer, recently shared a surprising tidbit about one ...

French drug major Sanofi (SNY) and Regeneron Pharmaceuticals, Inc. (REGN) announced Friday that the U.S. Food and Drug Administration ...

MIAMI and BARRANQUILLA, Colombia, Nov. 15, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: PROC) (“Procaps” or the “Company”), announced ...

The US Food and Drug Administration (FDA) has accepted for review the resubmission of the supplemental biologics license application (sBLA) for Dupixent (dupilumab) to treat adults and pediatric ...